Home

Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH
Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation
Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Compliance Manager
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Acoustic Mass Spectrometry
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community

Resources

JALA Special Issue
Publications
Articles and Other Media
Application Notes
Posters
Webinars
Videos
Customer Profiles
Core Labs

Support

Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Meet Labcyte
Careers
Contact and Location
Privacy Policy

Labcyte®
BLOG

Labcyte BLOG

SEARCH BLOGS

  • Precision at the Heart of Precision Oncology

    The future of precision oncology is happening now, in the labs of Seattle-based start-up SEngine, where individual patient tumor cells are screened against a library of nearly 150 drugs to find the optimal personalized treatment.

    > READ MORE
  • Hopping Over the Hype of Precision Medicine

    If we want to win the race against cancer, we cannot rely solely on genomics-based testing, argues Senior Research Fellow Joe Olechno in an article that appeared in Medicine Maker.

    > READ MORE
  • FIMM Extends Personalized Medicine Collaboration with Labcyte

    It’s brought unparalleled levels of precision to precision medicine, and enabled cancer treatment to be truly tailored to individual patients. Now Labcyte’s acoustic liquid handling technology will help the Institute for Molecular Medicine Finland (FIMM) take its innovative functional cell screening strategies to the next level.

    > READ MORE
  • Interlaboratory Reproducibility of ddPCR Using a New DNA Reference Material Format

    Whether it be pathogen detection, biomarker quantification or genome editing, polymerase chain reaction (PCR) technology is being used across a multitude of the life sciences, due to its unprecedented levels of precision, accuracy and resolution. There is great interest in moving the latest iteration of this technology — droplet digital PCR (ddPCR) — from research labs to clinical settings, but it will require processes for method validation, verification and reproducibility.

    > READ MORE
  • Get to Know the People at Labcyte!

    We have launched a new section on our website dedicated to profiling our company’s greatest asset – our people. We will continue to add new profiles on a regular basis, and to feature employees from a range of departments. We’re asking them about their jobs, what excites them about their work, career advice, what they do outside of the office, and more. This is a great way to learn more about your sales manager, customer service rep or application scientist, and the many other people who make Labcyte tick.

    > READ MORE
  • Customer Spotlight: SEngine Precision Medicine

    The complex analysis of multiple data types is greatly needed in precision medicine, according to Fred Hutchinson Cancer Research Center scientist Carla Grandori. She’s striving to meet that need via SEngine, a Seattle-based enterprise that harnesses the power of genomics and robotics to create truly tailored treatment assessments for those with cancer.

    > READ MORE
  • Nature Medicine Perspective Piece on Functional Precision Cancer Medicine

    In a recent Perspective piece in Nature Medicine, Dana Farber cancer researcher Tony Letai, M.D., Ph.D., makes a compelling case for focusing more attention and resources on the functional application of precision medicine, rather than pure genomics.

    > READ MORE
  • Scientists with Silicon Brains?

    Science Magazine recently published a feature article about how technologies such as the Echo Liquid Handlers are replacing human scientists to make processes more automated and efficient. Describing the lab at Labcyte customer Zymergen, a synthetic biology company in Emeryville, CA, the author writes “Instead of using a pipette to suck up and squirt microliters of liquid into each well – a tidal wave of volume on the cellular scale – the robot never touches it. Instead, 500 times per second, a pulse of sound waves causes the liquid itself to ripple and launch a droplet a thousand times smaller than one a human can transfer.”

    > READ MORE
 
TOP